K. Imazeki

Change of cerebral glucose metabolism by antineoplastic drug.

S. Minoshima, J. Itami, H. Maruno, 1991, American journal of physiologic imaging.

[Evaluation of gastroenterological disease by using 18F-FDG PET--differential diagnosis of malignancy from benignity].

H. Yamamoto, T. Kikuchi, T. Asano, 1992, Kaku igaku. The Japanese journal of nuclear medicine.

[Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].

H. Yamamoto, S. Okazumi, K. Isono, 1989, Kaku igaku. The Japanese journal of nuclear medicine.

The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.

S. Minoshima, J. Itami, H. Maruno, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[Evaluation of the cases of benign disease with high accumulation on the examination of 18F-fluorodeoxyglucose PET].

H. Yamamoto, T. Kikuchi, T. Asano, 1993, Kaku igaku. The Japanese journal of nuclear medicine.

Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET.

Y. Koide, K. Isono, S. Okazumi, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[Evaluation of clinical usefulness of 11C-methionine positron emission tomography (11C-MET-PET) as a tool for liver functional imaging].

H. Itoh, T. Asano, K. Yoshikawa, 1994, Kaku igaku. The Japanese journal of nuclear medicine.

[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].

H. Itoh, H. Yamamoto, T. Kikuchi, 1991, Kaku igaku. The Japanese journal of nuclear medicine.